<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="28638">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02733913</url>
  </required_header>
  <id_info>
    <org_study_id>PVI</org_study_id>
    <nct_id>NCT02733913</nct_id>
  </id_info>
  <brief_title>Clinical Impact of Autonomic Modulation After Pulmonary Vein Isolation</brief_title>
  <official_title>Clinical Impact of Autonomic Modulation After Pulmonary Vein Isolation in Patients With Paroxysmal Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinik f端r Kardiologie, Pneumologie und Angiologie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pulmonary vein isolation (PVI) has become a standard therapy for atrial fibrillation (AF),
      however, there is still considerable AF recurrence after PVI. Except for PV-left atrium (LA)
      reconnection, the cause of recurrence has been not yet fully clarified.

      The alternation of autonomic tone plays an important role in initiation of paroxysmal AF. It
      was reported that there are multiple gangliated plexus (GP) around pulmonary veins,
      therefore the modulation targeting those GPs, resulting in modulations of cardiac autonomic
      tone, have been conducted. Some study showed the efficacy of GP ablation for AF patients.

      According to the previous reports, heart rate (HR) increased, and heart rate variability
      (HRV) reduced after PVI. These are considered to be due to &quot;autonomic denervation&quot; caused by
      catheter ablation of GP.

      For the best of investigators knowledge, there have been no data on heart rate turbulence
      (HRT) of baroreflex sensitivity (BRS) concerning PVI.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>recurrence of AF</measure>
    <time_frame>12 months</time_frame>
    <description>Time measured in days to recurrence of AF</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>effect of PVI on cardiac autonomic system utilizing HRT measurement</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>effect of PVI on cardiac autonomic system utilizing BRS measurement</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>association between measured parameters (HRT, BRS) and the recurrence of AF</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Atrial Fibrillation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who undergo PVI for paroxysmal AF
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who undergo PVI for paroxysmal atrial fibrillation

          -  Patients in sinus rhythm at baseline

        Exclusion Criteria:

          -  prior left atrial Ablation

          -  left atrial diameter &gt;55mm

          -  frequent atrial extrasystole, frequent ventricular Extrasystole

          -  Diabetes Mellitus

          -  sleep apnea syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hisaki Makimoto, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Cardiology, Pulmonary Disease and Vascular Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hisaki Makimoto, MD</last_name>
    <phone>+492118118800</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rabea Wagstaff, M.A.</last_name>
    <phone>+492118118800</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Division of Cardiology, Pulmonary Disease and Vascular Medicine</name>
      <address>
        <city>D端sseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hisaki Makimoto, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Rabea Wagstaff, M.A.</last_name>
    </contact_backup>
    <investigator>
      <last_name>Hisaki Makimoto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dong-In Shin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christian Blockhaus, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 19, 2016</lastchanged_date>
  <firstreceived_date>February 18, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Klinik f端r Kardiologie, Pneumologie und Angiologie</investigator_full_name>
    <investigator_title>Klinik f端r Kardiologie, Pneumologie und Angiologie</investigator_title>
  </responsible_party>
  <keyword>atrial fibrillation</keyword>
  <keyword>pulmonary vein isolation</keyword>
  <keyword>heart rate turbulence</keyword>
  <keyword>baroreflex sensitivity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
